New Visions of CME: Hot Topics From the Alliance Sessions

Since 1992's one-two punch of renewed threats to regulate continuing medical education (CME) by the Food and Drug Administration (FDA), followed closely by the Clinton Administration's initiative to reinvent American healthcare, CME directors and coordinators seem to have spent a lot of time looking inward. The two big questions at the time were how to avoid regulation and how to survive a drought in commercial support.